Scarica l'app Stockscreener
2.53
7.66%
-0.21
Dopo l'orario di chiusura:
2.58
0.05
+1.98%
Rezolute Inc Borsa (RZLT) Ultime notizie
Despite Recent Gains, Rezolute Insiders Are Still Down US$77k - simplywall.st
Brokerages Set Rezolute, Inc. (NASDAQ:RZLT) PT at $24.38 - Defense World
Charles Schwab Investment Management Inc. Purchases 9,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Rezolute Director Makes Bold Stock Purchase - TipRanks
Rezolute director Hogenhuis purchases $19,733 in common shares - Investing.com
rezolute CEO Elam Nevan buys $34,999 in common shares By Investing.com - Investing.com Australia
rezolute CEO Elam Nevan buys $34,999 in common shares - Investing.com
Rezolute’s CFO Makes Bold Move with Major Stock Purchase! - TipRanks
Rezolute Appoints Erik Harris to Board of Directors - TipRanks
Rezolute CFO Daron Evans acquires $57,700 in common shares By Investing.com - Investing.com South Africa
Rezolute CFO Daron Evans acquires $57,700 in common shares - Investing.com India
Rezolute Inc (NASDAQ: RZLT): Getting A Free Pass? - Stocks Register
Rezolute expands board with biopharma veteran Erik Harris By Investing.com - Investing.com South Africa
Rezolute expands board with biopharma veteran Erik Harris - Investing.com
Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors - The Manila Times
Strategic Move: Ultragenyx CCO Erik Harris to Drive Rezolute's Rare Disease Commercialization - Stock Titan
Comparing Rezolute (NASDAQ:RZLT) & Akero Therapeutics (NASDAQ:AKRO) - Defense World
Here's Why Rezolute (RZLT) Looks Ripe for Bottom Fishing - Nasdaq
Analysts Set Rezolute, Inc. (NASDAQ:RZLT) Price Target at $24.38 - Defense World
JMP Securities lifts Rezolute stock target to $9, maintains rating - MSN
Rezolute, Inc. (NASDAQ:RZLT) Receives Average Rating of "Buy" from Analysts - MarketBeat
A Guide To The Risks Of Investing In Rezolute Inc (RZLT) - Knox Daily
Insider Buying: Wladimir Hogenhuis Acquires Additional Shares of Rezolute Inc (RZLT) - GuruFocus.com
Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares By Investing.com - Investing.com Nigeria
Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares - Investing.com India
Hedge Fund and Insider Trading News: Scott Bessent, Warren Buffett, Stanley Druckenmiller, Tybourne Capital Management, Millennium Management, Rezolute Inc (RZLT), Rambus Inc (RMBS), and More - Insider Monkey
Insider Trading Highlights: Wednesday's Key Moves in US Stocks - Investing.com
Short Interest in Rezolute, Inc. (NASDAQ:RZLT) Rises By 17.4% - MarketBeat
Rezolute director Kim Young-Jin buys $5 million in shares By Investing.com - Investing.com Australia
Rezolute director Kim Young-Jin buys $5 million in shares - Investing.com
Rezolute's SWOT analysis: biotech stock advances on ersodetug trials - MSN
Rezolute (NASDAQ:RZLT) Receives "Buy" Rating from HC Wainwright - MarketBeat
JMP Securities Issues Positive Forecast for Rezolute (NASDAQ:RZLT) Stock Price - MarketBeat
Rezolute: Late-Stage Study Targeting Hyperinsulinism (NASDAQ:RZLT) - Seeking Alpha
Rezolute’s SWOT analysis: biotech stock advances on ersodetug trials By Investing.com - Investing.com Nigeria
What is Wedbush’s Estimate for Rezolute FY2029 Earnings? - Defense World
What is Wedbush's Estimate for Rezolute FY2029 Earnings? - MarketBeat
What is HC Wainwright’s Estimate for Rezolute Q1 Earnings? - Defense World
Rezolute (NASDAQ:RZLT) Releases Quarterly Earnings Results, Beats Estimates By $0.11 EPS - MarketBeat
Rezolute’s Strategic Advances in Rare Disease Therapies - MSN
Guggenheim Reiterates Buy Rating for Rezolute (NASDAQ:RZLT) - MarketBeat
10.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):